TY - JOUR
T1 - CDC42 switches IRSp53 from inhibition of actin growth to elongation by clustering of VASP
AU - Disanza, Andrea
AU - Bisi, Sara
AU - Winterhoff, Moritz
AU - Milanesi, Francesca
AU - Ushakov, Dmitry S.
AU - Kast, David
AU - Marighetti, Paola
AU - Romet-Lemonne, Guillaume
AU - Müller, Hans Michael
AU - Nickel, Walter
AU - Linkner, Joern
AU - Waterschoot, Davy
AU - Ampè, Christophe
AU - Cortellino, Salvatore
AU - Palamidessi, Andrea
AU - Dominguez, Roberto
AU - Carlier, Marie France
AU - Faix, Jan
AU - Scita, Giorgio
PY - 2013/10/16
Y1 - 2013/10/16
N2 - Filopodia explore the environment, sensing soluble and mechanical cues during directional motility and tissue morphogenesis. How filopodia are initiated and spatially restricted to specific sites on the plasma membrane is still unclear. Here, we show that the membrane deforming and curvature sensing IRSp53 (Insulin Receptor Substrate of 53 kDa) protein slows down actin filament barbed end growth. This inhibition is relieved by CDC42 and counteracted by VASP, which also binds to IRSp53. The VASP:IRSp53 interaction is regulated by activated CDC42 and promotes high-density clustering of VASP, which is required for processive actin filament elongation. The interaction also mediates VASP recruitment to liposomes. In cells, IRSp53 and VASP accumulate at discrete foci at the leading edge, where filopodia are initiated. Genetic removal of IRSp53 impairs the formation of VASP foci, filopodia and chemotactic motility, while IRSp53 null mice display defective wound healing. Thus, IRSp53 dampens barbed end growth. CDC42 activation inhibits this activity and promotes IRSp53-dependent recruitment and clustering of VASP to drive actin assembly. These events result in spatial restriction of VASP filament elongation for initiation of filopodia during cell migration, invasion, and tissue repair.
AB - Filopodia explore the environment, sensing soluble and mechanical cues during directional motility and tissue morphogenesis. How filopodia are initiated and spatially restricted to specific sites on the plasma membrane is still unclear. Here, we show that the membrane deforming and curvature sensing IRSp53 (Insulin Receptor Substrate of 53 kDa) protein slows down actin filament barbed end growth. This inhibition is relieved by CDC42 and counteracted by VASP, which also binds to IRSp53. The VASP:IRSp53 interaction is regulated by activated CDC42 and promotes high-density clustering of VASP, which is required for processive actin filament elongation. The interaction also mediates VASP recruitment to liposomes. In cells, IRSp53 and VASP accumulate at discrete foci at the leading edge, where filopodia are initiated. Genetic removal of IRSp53 impairs the formation of VASP foci, filopodia and chemotactic motility, while IRSp53 null mice display defective wound healing. Thus, IRSp53 dampens barbed end growth. CDC42 activation inhibits this activity and promotes IRSp53-dependent recruitment and clustering of VASP to drive actin assembly. These events result in spatial restriction of VASP filament elongation for initiation of filopodia during cell migration, invasion, and tissue repair.
KW - CDC42
KW - IRSp53
KW - actin dynamics
KW - cell migration
KW - filopodia
UR - http://www.scopus.com/inward/record.url?scp=84885871112&partnerID=8YFLogxK
U2 - 10.1038/emboj.2013.208
DO - 10.1038/emboj.2013.208
M3 - Article
C2 - 24076653
AN - SCOPUS:84885871112
SN - 0261-4189
VL - 32
SP - 2735
EP - 2750
JO - EMBO Journal
JF - EMBO Journal
IS - 20
ER -